EMEA-001718-PIP01-14

Key facts

Active substance
  • 17 beta-estradiol
  • etonogestrel
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0028/2016
PIP number
EMEA-001718-PIP01-14
Pharmaceutical form(s)
Vaginal delivery system
Condition(s) / indication(s)
  • Treatment of dysmenorrhea
  • Prevention of pregnancy
Route(s) of administration
Vaginal use
Contact for public enquiries
Merck Sharp & Dohme (Europe), Inc.

Belgium
E- mail: pip.information@merck.com
Tel.: +31 412663179
Fax: +31 412662517

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating